The NIH Tetramer Facility is supported through National Institute of Allergy and Infectious Diseases (NIAID) contract 75N93020D00005, which includes co-funding from the National Cancer Institute (NCI). NIAID and NCI are components of the National Institutes of Health in the Department of Health and Human Services.
Notice Regarding Operations During the U.S. Government Shutdown
The NIH Tetramer Core Facility remains operational for previously approved orders. However, all new incoming requests must undergo review by NIH staff. Due to the current U.S. government shutdown, our NIH colleagues responsible for this review process are presently furloughed and unable to evaluate any submissions received after September 30, 2025.
While order submissions through this website remain open, we are unable to initiate work on newly submitted requests until the shutdown has concluded and NIH review activities resume.
Please also anticipate additional delays once normal operations restart, as a significant backlog of pending requests will require processing. Our facility operates with limited capacity, and recovery from the interruption will take time.